Transcept Pharmaceuticals (TSPT) 8.48 0.1905

Transcept Pharmaceuticals, Inc.
(TSPT) 8.48 0.1905

Last Trade:	8.4705	Day Range:	8.33 - 8.49
Trade Time:	12:02PM	52wk Range:	2.58 - 11.76
Prev. Close:	8.28	Market Cap:	114.68M
Open:	8.35	Div Yield:	0
Volume:	42497	PE:
EPS:	-0.87

The Latest On TSPT

Weekly Traders Homework: The First Sign Of Weakness In 2012 (w/ Economic Calendar & Stock Radar) 2/12/12 10:52pm

Weekly Homework: Wipe The 2011 Slate Clean (With Economic Calendar and Stock Radar) 1/2/12 8:38pm

End-of-Day Market Summary for December 21, 2011 12/21/11 4:25pm

Transcept Pharmaceuticals Receives $10M Milestone Payment from Purdue for Listing of Intermezzo Formulation Patents in FDA Orange Book 12/21/11 4:05pm

McNicoll, Lewis & Vlak Maintains Buy Rating and $21 PT on Transcept Pharmaceuticals 12/1/11 8:30am

Benzinga's Top Pre-Market Gainers 12/1/11 8:25am

Transcept Pharmaceuticals Announces That Purdue Has Exercised Option to Commercialize Intermezzo in U.S. 11/30/11 8:01pm

Transcept Pharmaceuticals Announces FDA Approval of Intermezzo For Use as Needed for the Treatment of Insomnia 11/23/11 1:56pm

McNicoll, Lewis & Vlak Reaffirms Transcept Pharmaceuticals Buy, $21 PT 11/14/11 3:09pm

Benzinga's Top Upgrades 11/1/11 6:58am

McNicoll Lewis & Vlak Upgrades Transcept Pharmaceuticals to Buy, $21 PT 11/1/11 4:55am

Transcept Pharmaceuticals Announces Intermezzo PDUFA Action Date of November 27, 2011 10/4/11 8:41am

Weekly Traders Homework: The First Sign Of Weakness In 2012 (w/ Economic Calendar & Stock Radar) 2/12/12

Weekly Homework: Wipe The 2011 Slate Clean (With Economic Calendar and Stock Radar) 1/2/12

End-of-Day Market Summary for December 21, 2011 12/21/11

Transcept Pharmaceuticals Receives $10M Milestone Payment from Purdue for Listing of Intermezzo Formulation Patents in FDA Orange Book 12/21/11

McNicoll, Lewis & Vlak Maintains Buy Rating and $21 PT on Transcept Pharmaceuticals 12/1/11

Benzinga's Top Pre-Market Gainers 12/1/11

Transcept Pharmaceuticals Announces That Purdue Has Exercised Option to Commercialize Intermezzo in U.S. 11/30/11

Transcept Pharmaceuticals Announces FDA Approval of Intermezzo For Use as Needed for the Treatment of Insomnia 11/23/11

McNicoll, Lewis & Vlak Reaffirms Transcept Pharmaceuticals Buy, $21 PT 11/14/11

Benzinga's Top Upgrades 11/1/11

McNicoll Lewis & Vlak Upgrades Transcept Pharmaceuticals to Buy, $21 PT 11/1/11

Transcept Pharmaceuticals Announces Intermezzo PDUFA Action Date of November 27, 2011 10/4/11

Weekly Traders Homework: The First Sign Of Weakness In 2012 (w/ Economic Calendar & Stock Radar) 2/12/12

Weekly Homework: Wipe The 2011 Slate Clean (With Economic Calendar and Stock Radar) 1/2/12

Tuesday's NASDAQ Top Gainers: Transcept, Kona Grill, Cumulus Media, Trimeris 9/21/11

Thursday's NASDAQ Top Gainers: Transcept, Fundtech, SRI/Surgical Express, Eastern Virginia Bankshares 9/16/11

Benzinga Value Investor Gave Subscribers a 40% Gain on Transcept Pharmaceuticals 9/15/11

TSPT Back in Play 9/15/11

Stocks to Watch for Thursday 7/28/2011: Fresh 52 Week Highs and Lows 7/28/11

Stocks to Watch for Tuesday 7/19/2011: Fresh 52 Week Highs and Lows 7/19/11

Stocks to Watch for Thursday 7/14/2011: Fresh 52 Week Highs and Lows 7/14/11

Biotech Investing Tips For 2011 2/13/11

Transcept Pharma Higher On SeekingAlpha Article (TSPT) 1/18/11

Benzinga's Top Pre-Market NASDAQ Gainers (CSCX, ACLS, TSPT, QGEN) 10/19/10

End-of-Day Market Summary for December 21, 2011 12/21/11

McNicoll, Lewis & Vlak Maintains Buy Rating and $21 PT on Transcept Pharmaceuticals 12/1/11

McNicoll, Lewis & Vlak Reaffirms Transcept Pharmaceuticals Buy, $21 PT 11/14/11

Benzinga's Top Upgrades 11/1/11

McNicoll Lewis & Vlak Upgrades Transcept Pharmaceuticals to Buy, $21 PT 11/1/11

McNicoll Lewis Vlak Raises PT on Transcept Pharmaceuticals to $8 9/28/11

McNicoll, Lewis & Vlak Downgrades Transcept Pharmaceuticals, Lowers PT 8/19/11

Lazard Capital Downgrades Transcept Pharmaceuticals To Neutral 7/18/11

Trade TSPT
NOW!

Partner Headlines

Research Analyst's New Ratings ( TSPT, CRIS, LPSN, SCOR ) 2/10/12

Weekly CFO Sells Highlight: DMAN, DISCA, TSPT, ONE, AKRX 12/12/11

Biotech Stock Live Chat 11/17/11

Transcept Pharmaceuticals Inc. Reports Operating Results (10-Q) 11/10/11

Biotech Calendar: Key Dates for November 11/1/11

Biotech Stock Mailbag: Somaxon, Transcept 10/7/11

Company News for October 5, 2011 - Corporate Summary 10/5/11

5 Stocks Insiders Think Are Worth It 9/28/11

Insiders Trading HNZ, JEF, ARUN, TSPT 9/23/11

Company News for September 16, 2011 - Corporate Summary 9/16/11

6 Stocks to Watch: Netflix, UBS 9/15/11

Clarcor, Transcept: After-Hours Trading 9/14/11

Press Releases

Transcept Pharmaceuticals to Present at Two Upcoming Investor Conferences 2/7/12 Newswire Story

Transcept Pharmaceuticals Receives $10 Million Milestone Payment from Purdue for Listing of Intermezzo Formulation Patents in FDA Orange Book 12/21/11 Newswire Story

Transcept Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011 12/8/11 Newswire Story

Transcept Pharmaceuticals to Host Conference Call to Discuss Purdue's Exercise of Option to Commercialize Intermezzo® in the United States 11/30/11 Newswire Story

Transcept Pharmaceuticals Announces Purdue's Exercise of Option to Commercialize Intermezzo® in the United States 11/30/11 Newswire Story

Focus on Growth Energy Stocks - Sunbelt International (SUNB) 11/25/11 Emailwire Story

Energy Stocks Today: Sunbelt International Clean Energy 11/25/11 Emailwire Story

Transcept Pharmaceuticals Announces FDA Approval of Intermezzo® (zolpidem tartrate sublingual tablet) C-IV For Use as Needed for the Treatment of Insomnia When a Middle-of-the-Night Awakening is Followed by Difficulty Returning to Sleep 11/23/11 Newswire Story

Transcept Pharmaceuticals to Host Conference Call to Discuss FDA Approval of Intermezzo® 11/23/11 Newswire Story

Transcept Pharmaceuticals Reports Third Quarter 2011 Financial Results 11/10/11 Newswire Story

Transcept Pharmaceuticals to Report Third Quarter 2011 Financial Results and Host Conference Call on November 10, 2011 11/2/11 Newswire Story

Transcept Pharmaceuticals to Present at the BIO Investor Forum on October 26, 2011 10/24/11 Newswire Story

Get the latest TSPT stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Transcept Pharmaceuticals, Inc. stock price.

Transcept Pharmaceuticals, Inc. by YCharts